Written by Alexa Heathorn, MS, CNS. Daily consumption of 60 g of tocotrienol-enriched oats for 12 weeks significantly increased HDL cholesterol while improving triglycerides, fasting blood glucose, blood pressure, body composition, and metabolic syndrome remission compared to a control group.

Metabolic syndrome (MetS) is a cluster of conditions characterized by impaired insulin sensitivity, hyperglycemia, dyslipidemia, abdominal obesity, and hypertension, that substantially increase the risk of type 2 diabetes, stroke, and cardiovascular disease.¹ With the prevalence of MetS reaching epidemic levels worldwide, there is growing interest in dietary strategies that complement standard medical care.¹ Whole grains, particularly oats, have been extensively studied for their ability to improve metabolic health due to their high content of antioxidants, phenolic compounds, and the soluble fiber, β-glucan.¹ Consumption of β-glucan has been shown to improve several cardiometabolic risk factors, including total and LDL cholesterol, blood pressure, waist circumference, body fat, and triglycerides.¹

More recently, researchers have turned their attention to tocotrienols, members of the vitamin E family with potent antioxidant and anti-inflammatory properties.¹ Human studies suggest tocotrienol supplementation may improve HDL cholesterol and triglyceride levels, although findings for other cardiometabolic markers have been inconsistent.¹ While both oats and tocotrienols have demonstrated individual benefits for metabolic health, their combined effects have not previously been evaluated.¹ To address this gap, researchers conducted a randomized, double-blind, placebo-controlled clinical trial to investigate whether tocotrienol-enriched oats could improve metabolic health in adults with metabolic syndrome.¹

The trial included 81 adults aged 18 years and older who met at least three criteria for metabolic syndrome. Participants were randomly assigned to one of three groups: the Toco Oat (TO) group, which received two daily sachets each containing 30 g of oats and 50 mg of tocotrienols; the Oat (O) group, which received two daily sachets each containing 30 g of oats; or the Control (C) group, which received no intervention.¹ The intervention lasted 12 weeks, and all participants continued their prescribed medications throughout the study. Primary outcomes were assessed at baseline and after 12 weeks and included changes in fasting blood glucose, blood pressure, triglycerides, HDL cholesterol, and waist circumference. Secondary outcomes included dietary intake, body composition assessed by bioelectrical impedance analysis (BIA), and health-related quality of life measured using a validated questionnaire.¹

The results following the 12-week intervention were promising. Compared to the control group, participants consuming tocotrienol-enriched oats were approximately twice as likely to experience remission of metabolic syndrome (37.0% vs. 18.5%).¹ The tocotrienol-enriched oat group also experienced significant improvements in several cardiometabolic risk factors, including a 34.1% increase in HDL cholesterol, a 7.1% reduction in triglycerides, a 4.5% reduction in fasting blood glucose, and decreases in both systolic (4.2%) and diastolic (5.3%) blood pressure.¹ In addition to these metabolic improvements, participants experienced a modest increase in muscle mass (+0.301 kg) and reduction in body fat (−0.775%).¹ Both the tocotrienol-enriched oat and oat-only groups also reported improvements in overall health-related quality of life and self-rated health scores compared to the control group.¹

One of the most notable findings was the 34.1% increase in HDL cholesterol, often referred to as the “good” cholesterol because it helps transport excess cholesterol from the bloodstream back to the liver for removal. The authors suggest this improvement may be due to tocotrienols increasing production of apolipoprotein A1 (ApoA1), the primary protein component of HDL particles, while also suppressing HMG-CoA reductase, a key enzyme involved in cholesterol synthesis.¹ Oats likely contributed as well, as their β-glucan content has been shown to support healthy lipid metabolism by reducing cholesterol absorption and promoting cholesterol clearance. However, because the study did not include a tocotrienol-only group, it is impossible to determine whether the observed improvements were driven primarily by the tocotrienols, the oats, or a synergistic effect of both ingredients.¹

Several limitations should be considered when interpreting these findings. The study included a relatively small sample size of 81 participants and was conducted at a single research center, which may limit the generalizability of the results. Additionally, the control group received no placebo intervention, making it difficult to rule out expectancy or behavioral bias. Because the trial did not include a tocotrienol-only group, it is also impossible to determine whether the observed benefits were driven primarily by the tocotrienols, the oats themselves, or a synergistic effect of the two. Participants continued taking their prescribed medications throughout the study, which may have influenced several cardiometabolic outcomes. Furthermore, the 12-week intervention provides only short-term data, and longer follow-up studies are needed to determine whether these improvements are sustained over time. Finally, body composition was assessed using bioelectrical impedance analysis (BIA) rather than a more precise method such as dual-energy X-ray absorptiometry (DXA), which may have affected the accuracy of the reported changes in body fat and muscle mass.

This study provides promising evidence that tocotrienol-enriched oats may offer greater cardiometabolic benefits than oats alone, particularly by increasing HDL cholesterol and improving overall metabolic syndrome remission. Although the findings require confirmation in larger and longer-term studies, they support the growing role of functional foods as a complementary strategy for improving metabolic health alongside standard medical care.

Click here to read the full text study.

Posted July 21, 2026.

Alexa Heathorn, MS, CNS-c, is a clinical nutritionist specializing in metabolic health, hormonal balance, and gastrointestinal restoration through root-cause functional nutrition. She earned her master’s degree in Nutrition from Bastyr University and is currently a Certified Nutrition Specialist (CNS) candidate. Alexa also works as a research writer and functional health consultant, translating complex science into actionable strategies for practitioners and wellness companies. Learn more at www.bloomedwellness.com.

Reference:

1. Norazman, Camilla Wahida, Mastura Mohd Sopian, and Lai Kuan Lee. “Effects of tocotrienol-enriched oat supplementation on metabolic profile, nutritional status and health-related quality of life among patients with metabolic syndrome.” Food & Function 16, no. 5 (2025): 1847-1863.